Physician profile
Robert D Matheney
NPI 1356307177
$9,979.85
in general payments reported to CMS, 2019-2025
34 companies · $3,624 in 2025
The $3,624 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,751 · 2020: $188 · 2021: $702 · 2022: $923 · 2023: $1,576 · 2024: $1,217 · 2025: $3,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,817 · Travel and Lodging: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,817.05 |
| Travel and Lodging | $1,598.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,457.74 | 2023-2025 | Micra, Linq II, Resolute Onyx |
| Novartis Pharmaceuticals Corporation | $1,730.10 | 2019-2025 | |
| Abiomed | $844.01 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $594.68 | 2019-2024 | Xarelto |
| Amgen INC. | $536.84 | 2019-2024 | Repatha |
| Medtronic Vascular, INC. | $379.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $347.12 | 2019-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $305.17 | 2022-2025 | Onpattro |
| Pfizer INC. | $297.25 | 2019-2025 | |
| Atricure, INC. | $270.97 | 2023-2025 | Synergy Ablation System |
| Edwards Lifesciences Corporation | $268.46 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $224.35 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.65 | 2022-2025 | Jardiance |
| Abbott Laboratories | $160.52 | 2019-2025 | Gallant, Assurity |
| Shockwave Medical, INC | $152.89 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $149.20 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $138.08 | 2024-2025 | Verquvo |
| Biotronik INC. | $124.99 | 2019 | |
| Baxter Healthcare | $104.38 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $92.49 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.28 | 2019-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $85.02 | 2022-2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $78.08 | 2023-2024 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $66.12 | 2019-2021 | |
| Cvrx, INC. | $49.05 | 2023 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $40.13 | 2019 | |
| Irhythm Technologies, INC. | $39.72 | 2023 | Zio Xt Patch |
| Lantheus Medical Imaging, INC. | $27.18 | 2024 | |
| Amarin Pharma, INC. | $26.42 | 2019 | |
| Novo Nordisk INC | $22.35 | 2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $21.10 | 2023 | |
| Terumo Medical Corporation | $16.40 | 2024 | Angio-Seal, Metacross Otw |
| Philips North America LLC | $15.70 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Esperion Therapeutics, INC. | $14.74 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Matheney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.